Management of the Triple Negative Locally Advanced Breast Cancer
One out of eight women is suffering from the breast cancer. 2.3 million New cases is predicted by 2023 worldwide. Triple negative breast cancer (TNBC) is having 10–15% incidence. As categorized with the lack of estrogen, progesterone and human epidermal growth factor receptor 2 neu receptor expressi...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/86445 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Management of the Triple Negative Locally Advanced Breast Cancer
- Radiologic Features of Triple Negative Breast Cancer
- Experimental Therapeutics for the Treatment of Triple Negative Breast Cancer
- FZD7 in Triple Negative Breast Cancer Cells
- Molecular Prognostic and Predictive Markers in Triple - Negative Breast Cancer
- Inter-Relationship of Ki-67 and Triple-Negative Breast Cancer
- Neuropilin-1: A Promising Therapeutic Target for Triple-Negative Breast Cancer